td-0714
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2015 (NCT02639078)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- NeprilysinINHIBITOR
MME inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- td-0714
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02709928 | Phase 1 | Mar 1, 2016 | Celerion, Theravance |
| NCT02639078 | Phase 1 | Nov 1, 2015 | Celerion, Theravance |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Celerion | For profit | 2 | 0 | 1 | 2015 |
| Theravance | For profit | 2 | 2 | 1 | 2015 |
2 organizations
Page 1 / 1